Log In
BCIQ
Print this Print this
 

tilSEQ

  Manage Alerts
Collapse Summary General Information
Company Adaptive Biotechnologies Corp.
DescriptionTest to quantify the presence and clonality of tumor infiltrating lymphocytes (TILs) in solid tumors
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard IndicationCancer, Diagnostic
Indication DetailsQuantify clonality of tumor infiltrating lymphocytes (TILs) in solid tumor
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today